* Biotricity Inc BTCY.OQ BTCY.O is expected to show a
rise in
quarterly revenue when it reports results on August 14
(estimated).
* The Redwood City California-based company is expected to
report
a 50.8% increase in revenue to $3.1 million from $2.06 million
a year ago, according to the estimate from one analyst, based on
Refinitiv data.
* Refinitiv's mean analyst estimate for Biotricity Inc is
for a
loss of 41 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Biotricity
Inc is
$4, above its last closing price of $2.47.
This summary was machine generated August 12 at 02:06 GMT. All
figures in US dollars unless otherwise stated